| A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis JA Herman, F Khalighinejad, K York, I Radu, IB Morales, C Ionete, ... Multiple Sclerosis and Related Disorders 47, 102619, 2021 | 18 | 2021 |
| The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort DAP Maldonado, JR Eusebio, L Amezcua, ES Vasileiou, EM Mowry, ... Multiple sclerosis and related disorders 58, 103451, 2022 | 16 | 2022 |
| Multi-omics analysis of magnetically levitated plasma biomolecules AA Ashkarran, H Gharibi, D Abou Zeki, I Radu, F Khalighinejad, ... Biosensors and Bioelectronics 220, 114862, 2023 | 2 | 2023 |
| Towards a Due Foundation for Image Based Discrimination of Multiple Sclerosis Disease Types Using Magnetic Levitation and Vision Intelligence M Ramezankhani, T Olfatbakhsh, A Ashkarran, D Abou Zeki, I Radu, ... Preprints, 2022 | 1 | 2022 |
| THROMBOXANE RECEPTOR BLOCKADE WITH IFETROBAN IMPROVES VASOREACTIVITY MEASURED BY BRACHIAL FLOW-MEDIATED DILATATION FMD BUT NOT BY PERIPHERAL ARTERIAL TONOMETRY IN PATIENTS WITH … IA Radu, E Hariri, D Bunsick, NM Hamburg, BA Barton, JJ Rade Journal of the American College of Cardiology 83 (13_Supplement), 1162-1162, 2024 | | 2024 |
| Health behavior outcomes in stroke survivors prescribed wearables for atrial fibrillation detection stratified by age J Mathew, J Mehawej, Z Wang, T Orwig, E Ding, A Filippaios, S Naeem, ... Journal of Geriatric Cardiology: JGC 21 (3), 323, 2024 | | 2024 |
| Targeted CSF Proteomics As a Tool for Analyzing Immunophenotype Heterogeneity in Multiple Sclerosis S Kumar, K Afshari, A Rabin, F Khalighinejad, N Francis, F Qutab, ... 2022 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2022 | | 2022 |
| Evaluating Treatment Responsiveness and Disease Activity in Multiple Sclerosis Patients Using High-Resolution Immune Profiling S Kumar, K Afshari, A Rabin, F Khalighinejad, N Francis, F Qutab, ... MULTIPLE SCLEROSIS JOURNAL 28 (1_ SUPPL), 32-32, 2022 | | 2022 |
